Tekmira initiated with Outperform rating

Leerink initiated coverage of Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) with an Outperform rating and a price target of $25 lifting the stock price $1.71 to $19.79.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.